Navigation Links
Colleen Goggins, Worldwide Chairman, Consumer Group Plans Retirement From Johnson & Johnson in Early 2011
Date:9/16/2010

NEW BRUNSWICK, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) said today that Colleen Goggins, 56, Worldwide Chairman, Consumer Group, has announced her retirement from the Company effective March 1, 2011, after a successful and distinguished career spanning almost 30 years.

William C. Weldon, Chairman and CEO, said, "Throughout her tenure, Colleen has demonstrated our commitment to our consumers and our people, and has made major contributions to our success.  We thank Colleen for her dedication and extraordinary service, and wish her all the best in the years to come."

Ms. Goggins joined Johnson & Johnson in 1981, working in various assignments of increasing responsibility.  She became President of Johnson & Johnson Canada in 1992; President, Personal Products Company, U.S. in 1994; and President, Johnson & Johnson Consumer Companies Inc. in 1995.  She was promoted to Company Group Chairman in 1998.  Colleen assumed her current position as a member of the Executive Committee in June 2001.

Mr. Weldon added: "Colleen is among the group of executives that have led the effort to formulate and implement the remediation plan regarding the quality issues at McNeil.  In light of Colleen's decision to retire, I am pleased that we have a clear remediation plan in place and we will work together to ensure a smooth transition of her responsibilities. We will make a timely announcement of succession plans for this critical position for the Company."


'/>"/>
SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016
2. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
3. TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System
4. Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
5. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
6. Eye-Fi Expands Hotspot Access Service Worldwide
7. Orbitz Worldwide, Inc. to Host First Quarter 2010 Earnings Call on May 5
8. Best Practice Adopted Worldwide From Norway to Australia
9. Elekta VMAT Radiation Therapy Rapidly Gaining Users Worldwide as Technique Evolves
10. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
11. Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... LAVAL, Quebec , March 27, 2015  Valeant ... announced today the closing of its previously announced registered ... States (the "Offering"). Pursuant to the Offering, ... of $199.00 per share, for aggregate gross proceeds of ... filed with the U.S. Securities and Exchange Commission a ...
(Date:3/27/2015)... March 27, 2015  RXi Pharmaceuticals Corporation ... LLC, today announced that they have entered ... novel and proprietary sd-rxRNA® technology for use ... collaboration has the potential to result in ... treatments that could be a significant step ...
(Date:3/27/2015)... 27, 2015  WebMD Health Corp. (NASDAQ: ... health information, today announced an exclusive White ... Action Plan for Combating Antibiotic-Resistant Bacteria . ... urgency and importance of addressing antibiotic-resistant bacteria ... health.    The WebMD interview, available ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3
... , , , ... leading developer of medical device technology for the safe ... new Webinar program supporting its culture of safety initiative ... "A Culture of Safety in Pharmacy: Lessons Learned," features ...
... , MOUNTAIN VIEW, Calif., Dec. 29 VIVUS, Inc. (Nasdaq: ... therapies to address unmet needs in obesity, diabetes and sexual ... been submitted to the U.S. Food and Drug Administration (FDA) ... of obesity, including weight loss and maintenance of weight loss, ...
Cached Medicine Technology:Baxa Corporation to Sponsor Free Culture of Safety Webinar 2Baxa Corporation to Sponsor Free Culture of Safety Webinar 3VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 2VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 3VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 4VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 5
(Date:3/27/2015)... 27, 2015 On February 21, ... in the Stardust Penthouse on the rooftop of ... Angeles’ leading sustainable product TV and film placement ... day-long event, which featured some of the world’s ... products and services. , “We were honored to ...
(Date:3/27/2015)... March 27, 2015 According to a ... ), the plate and screw market in Europe is ... generic plate and screw segment. Price decreases are being ... representing almost 50% of the total European trauma device ... the total market value, year after year. , ...
(Date:3/27/2015)... 2015 According to Health Day ... with Neonatal Abstinence Syndrome (NAS) are causing alarm for ... painful withdrawal process for a month of their lives- ... diarrhea, and vomiting. The condition is precipitated by drug ... addiction treatment (and employing medically assisted drug treatment) will ...
(Date:3/27/2015)... March 27, 2015 When struck with ... hard to know where to begin. The latest ... trucking accident attorney, offers accident victims a clear and ... assistance to ensure their personal injury claim is seen ... describing the first actions that should be taken immediately ...
(Date:3/27/2015)... Texas (PRWEB) March 27, 2015 ... Glutathione Industry is a professional and in-depth study ... glutathione market with a focus on the ... overview of the industry including definitions, classifications, applications ... is provided for both the international and Chinese ...
Breaking Medicine News(10 mins):Health News:Choices Recovery Releases 'Salute to the Oscars' EcoLuxe Lounge Compilation Video 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 3
... nutritional supplements ... in North ... Alliance,(CWA), experts in designing custom wellness programs for consumers and,corporations, ... announcement was made by biochemist, Lyle MacWilliam, author,of the recently ...
... many,people who have called and asked how they could help, ... with Tony Snow,s children,s education and,expenses., Jill Snow, Tony,s ... Kendall, Robbie and Kristi, as beneficiaries. Donations can,be made directly ... check,made payable to the "Tony Snow Family Trust" to:, ...
... ANGELES, July 14 The Cooperative of American,Physicians, ... exceeded 10,000 physicians., "Surpassing the 10,000 member ... CEO James L. Weidner. "The physicians who founded,CAP ... They believed that,physicians working together could find a ...
... with upbeat outlook, but same did not hold true for women ... had a lower risk of dying from heart disease turned out ... their conventional risk factors showed. , The death rate for men ... of those who listed themselves as being at average risk, said ...
... The Medical Device,Manufacturers Association (MDMA), a national trade ... the Board of Directors at the,MDMA Annual Meeting ... http://www.newscom.com/cgi-bin/prnh/20041004/MDMALOGO ), "I am honored to ... Manufacturers,Association," stated Root. "MDMA has a long history ...
... in heart and travels to the brain, heparin more risky, ... widely prescribed blood-thinning drug heparin is associated with an increased ... cardioembolic stroke, new research shows. , But another thinning ... in the same group of patients. , This finding led ...
Cached Medicine News:Health News:Vitalize(TM) Receives Top Multivitamin Rating 2Health News:Cooperative of American Physicians Membership Tops 10,000 2Health News:Optimism About Heart Risk Pays Off 2Health News:Vascular Solutions CEO Elected to MDMA Board of Directors 2Health News:Warfarin Safer Than Heparin for Some Strokes 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: